RR

Ramalingeswara Rao Vijjapu

Active Director Director DIN 10888566
DIN 10888566 First appointment Dec 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramalingeswara Rao Vijjapu

Data last updated:

Ramalingeswara Rao Vijjapu is a Director at Qt Med Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10888566
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Dec 20242024Active

Board colleagues of Ramalingeswara Rao Vijjapu

NameDINCompanyDesignation
Ganesh Kumar Patri06442999Qt Med Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Qt Med Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramalingeswara Rao Vijjapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramalingeswara Rao Vijjapu

Ramalingeswara Rao Vijjapu currently holds 1 directorship: Qt Med Pharmaceuticals Private Limited (Director, since 27 Dec 2024).

Ramalingeswara Rao Vijjapu was first appointed on 27 Dec 2024 as Director at Qt Med Pharmaceuticals Private Limited.

The current boards of Ramalingeswara Rao Vijjapu's companies include Ganesh Kumar Patri (Qt Med Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available